Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates

NCT07088302 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-01-16

No results posted yet for this study

Summary

This study aims to study the effect of lactase enzyme in preventing feeding intolerance in preterm neonates in neonatal intensive care unit at Alexandria University Children's Hospital.

Conditions

  • Premature
  • Feeding Disorders
  • Lactase Deficiency, Congenital

Interventions

DRUG

lactase administration

1 drop for each 10 ml of formula milk for 14 days

OTHER

placebo

10 ml milk without lactase

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Days
Max Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-30
Primary Completion
2026-02-28
Completion
2026-03-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07088302 on ClinicalTrials.gov